1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)urea

Catalog No. :
ACWQDT723
CAS No. :
2814571-30-5
Molecular Formula :
C28H25F2N7O4S
Molecular Weight :
593.62

IUPAC Name:1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)urea

1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)urea structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)urea
IUPAC Name1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)urea
Molecular FormulaC28H25F2N7O4S
Molecular Weight593.62
SMILESCOC1=NN=C(N2C(=O)C3=C(SC(C4=CC=C(NC(N)=O)C=C4)=C3CN(C)C)N(CC3=C(F)C=CC=C3F)C2=O)C=C1
InChI KeyOZHVFUYWASAETJ-UHFFFAOYSA-N
SynonymRelugolix Impurity 120
CAS No.2814571-30-5

Synthetic Route by SureRoute

1. ACWQDT723 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWQDT723 route product structure diagram
    ACWQDT7232814571-30-5
Inquiry

2. ACWQDT723 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWQDT723 route product structure diagram
    ACWQDT7232814571-30-5
Inquiry

Comments (0)